This bill amends current New Jersey law to allow health care providers to prescribe Schedule II controlled dangerous substances via telemedicine or telehealth without requiring an initial in-person examination or subsequent in-person visits, provided certain conditions are met. These conditions include ensuring that the telemedicine encounter adheres to the standard of care as if it were conducted in person, that the prescription is issued for a legitimate medical purpose, and that the communication occurs through an interactive, real-time, two-way audio-visual system. Additionally, the bill specifies that if a health care provider is prescribing a stimulant classified as a Schedule II controlled substance for a minor, they must obtain written consent from the minor's parent or guardian to waive the in-person examination requirement.

The bill also clarifies that mental health screeners and psychiatrists can conduct evaluations via telemedicine without needing separate authorization or waivers, and it mandates that health care providers maintain complete records of patient care while complying with relevant state and federal regulations. Overall, this legislation aims to enhance access to necessary medications while ensuring that telemedicine practices meet established standards of care.

Statutes affected:
Introduced: 45:1-62